$MNKD Headlines Skullcandy gains on upgrade,Te
Post# of 88933
Posted On: 10/30/2014 10:22:15 AM
$MNKD Headlines
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
MannKind: What The Market's Implying, And Why It's Wrong. 8:18 a.m. Today - Seeking Alpha
MannKind: What To Expect From Earnings 11:20 a.m. Oct. 29, 2014 - Seeking Alpha
How MannKind Long Investors Can Profit From Short Raids 8:52 a.m. Oct. 28, 2014 - Seeking Alpha
MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 28, 2014 - Zacks.com
MNKD: 17 Weeks and 58% Later, MannKind Stock FINALLY Is a Buy 7:15 a.m. Oct. 28, 2014 - InvestorPlace.com
Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction Platform In Diabetes 4:16 a.m. Oct. 28, 2014 - Seeking Alpha
Biotech Short Interest Becomes Stock Specific 9:47 a.m. Oct. 27, 2014 - 247WallSt.com
5 Stocks With Ugly Sales Growth — HTS MITT UEC MNKD CTEL 5:45 a.m. Oct. 27, 2014 - InvestorPlace.com
MannKind: Massive Short Interest Could Lead To Big Gains 3:28 p.m. Oct. 24, 2014 - Seeking Alpha
Cramer's Mad Money - Turbulence At Boeing (10/23/14) 5:43 a.m. Oct. 24, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD CBST INCY ISIS 1:15 p.m. Oct. 23, 2014 - InvestorPlace.com
MannKind Corporation Stock: Unloved and Unbelievably Attractive 7:42 a.m. Oct. 23, 2014 - InvestorPlace.com
FDA accepts Lilly's NDA for type 2 diabetes combo 10:52 a.m. Oct. 21, 2014 - Seeking Alpha
Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade 12:46 p.m. Oct. 20, 2014 - 247WallSt.com
Top Analyst Upgrades and Downgrades: AIG, Align Tech, Cliffs, Cyber-Ark, MannKind, Micron and More 7:46 a.m. Oct. 20, 2014 - 247WallSt.com
5 Stocks With Poor Sales Growth — HTS MITT UEC MNKD CTEL 4:30 a.m. Oct. 20, 2014 - InvestorPlace.com
MannKind: 5 Potential Technosphere Applications 8:38 a.m. Oct. 18, 2014 - Seeking Alpha
Discovery Laboratories: Collaboration With Battelle Is Validation Of Aerosurf's Potential By A Sophisticated Third Party 8:16 a.m. Oct. 17, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com
MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape 9:46 a.m. Oct. 16, 2014 - Zacks.com
Insider Trading Buzz for Twitter, Delta Air Lines, Apple, GoPro, GT Advanced Technologies, and MannKind 8:45 a.m. Oct. 28, 2014 - PR Newswire - PRF
MannKind Corporation to Hold 2014 Third Quarter Financial Results Conference Call on November 3, 2014 5:00 p.m. Oct. 27, 2014 - GlobeNewswire
Earnings Forecast Research for DryShips, GoPro, Gilead Sciences, MannKind, GT Advanced Technologies, and Amazon 8:45 a.m. Oct. 27, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Alibaba, Yahoo!, El Pollo Loco and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Oct. 23, 2014 - PR Newswire - PRF
Insider Trading Alerts for Micron, CSX, Ariad Pharmaceuticals, IBM, SinoCoking Coal and Coke Chemical, and MannKind 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Insider Trading Research for Halliburton, Ariad Pharmaceuticals, KeyCorp, GoPro, MannKind, and Plug Power 8:45 a.m. Oct. 20, 2014 - PR Newswire - PRF
Earnings Forecast Alerts for Apple, Intel, MannKind, GoPro, Plug Power, and Cliffs Natural Resources 8:45 a.m. Oct. 16, 2014 - PR Newswire - PRF
Latest Insider Trading for FuelCell Energy, Flextronics, MannKind, GT Advanced Technologies, Plug Power, and GoPro 8:55 a.m. Oct. 15, 2014 - PR Newswire - PRF
Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma 9:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Free Earnings Forecast for GoPro, Glu Mobile, Frontier Communications, Plug Power, Cliffs Natural Resources, and MannKind 8:30 a.m. Oct. 8, 2014 - PR Newswire - PRF
Insider Trading Research for CareFusion, Arch Coal, Netflix, Cliffs Natural Resources, MannKind, and Plug Power 8:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Sarepta Therapeutics, Noodles & Company, VoxelJet and Lululemon Released By InvestorsObserver 9:31 a.m. Oct. 3, 2014 - PR Newswire - PRF
Insider Trading Alerts for Comcast, RF Micro Devices, Broadcom, GoPro, MannKind, and Yahoo 8:55 a.m. Oct. 3, 2014 - PR Newswire - PRF
MannKind Announces Receipt of $150 Million Licensing Upfront Payment 7:30 p.m. Sept. 29, 2014 - GlobeNewswire
Insider Trading Reports for Apple, Cisco, Yahoo, Tesla, MannKind, and Bank of America 8:30 a.m. Sept. 29, 2014 - PR Newswire - PRF
Insider Trading Alerts for Facebook, Apple, Cisco, Verizon, MannKind, and Tesla Motors 8:55 a.m. Sept. 26, 2014 - PR Newswire - PRF
MannKind Announces Closing of Global Licensing Agreement With Sanofi 5:00 p.m. Sept. 24, 2014 - GlobeNewswire
Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference 5:00 p.m. Sept. 2, 2014 - GlobeNewswire
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
MannKind: What The Market's Implying, And Why It's Wrong. 8:18 a.m. Today - Seeking Alpha
MannKind: What To Expect From Earnings 11:20 a.m. Oct. 29, 2014 - Seeking Alpha
How MannKind Long Investors Can Profit From Short Raids 8:52 a.m. Oct. 28, 2014 - Seeking Alpha
MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 28, 2014 - Zacks.com
MNKD: 17 Weeks and 58% Later, MannKind Stock FINALLY Is a Buy 7:15 a.m. Oct. 28, 2014 - InvestorPlace.com
Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction Platform In Diabetes 4:16 a.m. Oct. 28, 2014 - Seeking Alpha
Biotech Short Interest Becomes Stock Specific 9:47 a.m. Oct. 27, 2014 - 247WallSt.com
5 Stocks With Ugly Sales Growth — HTS MITT UEC MNKD CTEL 5:45 a.m. Oct. 27, 2014 - InvestorPlace.com
MannKind: Massive Short Interest Could Lead To Big Gains 3:28 p.m. Oct. 24, 2014 - Seeking Alpha
Cramer's Mad Money - Turbulence At Boeing (10/23/14) 5:43 a.m. Oct. 24, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD CBST INCY ISIS 1:15 p.m. Oct. 23, 2014 - InvestorPlace.com
MannKind Corporation Stock: Unloved and Unbelievably Attractive 7:42 a.m. Oct. 23, 2014 - InvestorPlace.com
FDA accepts Lilly's NDA for type 2 diabetes combo 10:52 a.m. Oct. 21, 2014 - Seeking Alpha
Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade 12:46 p.m. Oct. 20, 2014 - 247WallSt.com
Top Analyst Upgrades and Downgrades: AIG, Align Tech, Cliffs, Cyber-Ark, MannKind, Micron and More 7:46 a.m. Oct. 20, 2014 - 247WallSt.com
5 Stocks With Poor Sales Growth — HTS MITT UEC MNKD CTEL 4:30 a.m. Oct. 20, 2014 - InvestorPlace.com
MannKind: 5 Potential Technosphere Applications 8:38 a.m. Oct. 18, 2014 - Seeking Alpha
Discovery Laboratories: Collaboration With Battelle Is Validation Of Aerosurf's Potential By A Sophisticated Third Party 8:16 a.m. Oct. 17, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com
MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape 9:46 a.m. Oct. 16, 2014 - Zacks.com
Insider Trading Buzz for Twitter, Delta Air Lines, Apple, GoPro, GT Advanced Technologies, and MannKind 8:45 a.m. Oct. 28, 2014 - PR Newswire - PRF
MannKind Corporation to Hold 2014 Third Quarter Financial Results Conference Call on November 3, 2014 5:00 p.m. Oct. 27, 2014 - GlobeNewswire
Earnings Forecast Research for DryShips, GoPro, Gilead Sciences, MannKind, GT Advanced Technologies, and Amazon 8:45 a.m. Oct. 27, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Alibaba, Yahoo!, El Pollo Loco and Activision Blizzard Released By InvestorsObserver 9:31 a.m. Oct. 23, 2014 - PR Newswire - PRF
Insider Trading Alerts for Micron, CSX, Ariad Pharmaceuticals, IBM, SinoCoking Coal and Coke Chemical, and MannKind 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Insider Trading Research for Halliburton, Ariad Pharmaceuticals, KeyCorp, GoPro, MannKind, and Plug Power 8:45 a.m. Oct. 20, 2014 - PR Newswire - PRF
Earnings Forecast Alerts for Apple, Intel, MannKind, GoPro, Plug Power, and Cliffs Natural Resources 8:45 a.m. Oct. 16, 2014 - PR Newswire - PRF
Latest Insider Trading for FuelCell Energy, Flextronics, MannKind, GT Advanced Technologies, Plug Power, and GoPro 8:55 a.m. Oct. 15, 2014 - PR Newswire - PRF
Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma 9:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Free Earnings Forecast for GoPro, Glu Mobile, Frontier Communications, Plug Power, Cliffs Natural Resources, and MannKind 8:30 a.m. Oct. 8, 2014 - PR Newswire - PRF
Insider Trading Research for CareFusion, Arch Coal, Netflix, Cliffs Natural Resources, MannKind, and Plug Power 8:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Sarepta Therapeutics, Noodles & Company, VoxelJet and Lululemon Released By InvestorsObserver 9:31 a.m. Oct. 3, 2014 - PR Newswire - PRF
Insider Trading Alerts for Comcast, RF Micro Devices, Broadcom, GoPro, MannKind, and Yahoo 8:55 a.m. Oct. 3, 2014 - PR Newswire - PRF
MannKind Announces Receipt of $150 Million Licensing Upfront Payment 7:30 p.m. Sept. 29, 2014 - GlobeNewswire
Insider Trading Reports for Apple, Cisco, Yahoo, Tesla, MannKind, and Bank of America 8:30 a.m. Sept. 29, 2014 - PR Newswire - PRF
Insider Trading Alerts for Facebook, Apple, Cisco, Verizon, MannKind, and Tesla Motors 8:55 a.m. Sept. 26, 2014 - PR Newswire - PRF
MannKind Announces Closing of Global Licensing Agreement With Sanofi 5:00 p.m. Sept. 24, 2014 - GlobeNewswire
Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 9:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference 5:00 p.m. Sept. 2, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼